80
Diseases of the Uvea & Vitreous Vicente Victor D. Ocampo, Jr., MD, DPBO Pamantasan Ng Lungsod Ng Maynila

Diseases of the Uvea and Vitreous

Embed Size (px)

Citation preview

Page 1: Diseases of the Uvea and Vitreous

Diseases of the Uvea & Vitreous

Vicente Victor D. Ocampo, Jr., MD, DPBO

Pamantasan Ng Lungsod Ng Maynila

Page 2: Diseases of the Uvea and Vitreous

Objectives

• To discuss and differentiate the various diseases of the uveal tract

• To discuss and differentiate the various diseases of the vitreous

Page 3: Diseases of the Uvea and Vitreous

Uveal Tract

• Iris

• Ciliary Body

• Choroid

Page 4: Diseases of the Uvea and Vitreous

Uveal Tract

• Pigmented vascular middle coat

• From optic disc to pupil

• Blood supply from ophthalmic artery– CB & iris – Long ciliary arteries (2)– Choroid – Short ciliary arteries (10-20)

• Mesodermal in origin; CB & iris have neuro-ectodermal components also

Page 5: Diseases of the Uvea and Vitreous

Physiology

• Iris – regulates size of pupil

• Ciliary body– secretes aqueous humor– controls accommodative power of the eye

• Choroid – provides nourishment for RPE and outer retina

Page 6: Diseases of the Uvea and Vitreous

Uveitis

• Inflammation of uveal tract

• Compartmentalization due to separate distribution of blood supply

• Severity: Iris < CB < Choroid due to vascularity and cellularity

• May also involve adjacent structures like sclera,retina,vitreous,optic nerve

Page 7: Diseases of the Uvea and Vitreous

Classification of Uveitis

• Anatomical– Anterior

– Intermediate

– Posterior

– Panuveitis

• Clinical– Acute

– Chronic

– Recurrent

• Etiological– Exogenous– Endogenous

• Pathological– Granulomatous– Non-granulomatous

• Pathophysiology– Infectious– Inflammatory

Page 8: Diseases of the Uvea and Vitreous

Onset

• Sudden – pain,redness,photophobia

• Insidious – painless, white eye

Page 9: Diseases of the Uvea and Vitreous

Duration

• Limited – 3 mos or less

• Persistent > 3 mos

Page 10: Diseases of the Uvea and Vitreous

Clinical Course

• Acute– sudden onset, limited duration– many cells, severe flare

• Recurrent– repeated attacks separated by periods of

inactivity w/o tx of at least 3 mos

• Chronic– persistent inflammation w/in 3 mos after d/c of

tx

Page 11: Diseases of the Uvea and Vitreous

Pathology

• Granulomatous– chronic,insidious– large,mutton-fat kp's– ++ ps– ++ busacca nod– ++ koeppe nod– TB,VKH,SO, sarcoid

• Non-granulomatous– acute– smaller kp's– less likelihood fr ps– (-) busacca nod– +/- koeppe nods– most ant uveitides

Page 12: Diseases of the Uvea and Vitreous

Infectious Uveitis • Etiology

– Bacterial: TB, syphilis,staph– Fungal: Histoplasmosis, coccidiomycosis– Viral: HSV, HZV, CMV– Parasitic: Toxoplasmosis, toxocariasis

• Due to perforating injury (exogenous), infection in eye (ocular), or emboli from body (endogenous)

• Suppuration of uvea, retina, vitreous leads to endophthalmitis

Page 13: Diseases of the Uvea and Vitreous
Page 14: Diseases of the Uvea and Vitreous
Page 15: Diseases of the Uvea and Vitreous

Nomenclature

• Uveitis – inflammation of uveal tract

• Iritis – inflammation confined to anterior chamber

• Iridocyclitis – spill over to rentrolental space

• Keratouveitis – spill over to cornea

• Sclerouveitis – sclera + iris

Page 16: Diseases of the Uvea and Vitreous

Markers of Inflammation

• Cells• Flare• Keratic Precipitates• Iris Nodules

Page 17: Diseases of the Uvea and Vitreous

Cells and Flare

• Cells – sign of active inflammation• Aqueous flare – proteinaceus materials

leaking from damaged iris blood vessels

Page 18: Diseases of the Uvea and Vitreous

Keratic Precipitates• cellular aggregates that form on the corneal

endothelium

Page 19: Diseases of the Uvea and Vitreous

Iris Noodules• Bussaca

– in iris stroma– granulomatous

• Koeppe– pupil margin

Page 20: Diseases of the Uvea and Vitreous

Acute Anterior Uveitis

• Pain, redness, photophobia

• Several days to weeks

• Acute & unilateral

• Recurrences common

• 50-70% idiopathic

Page 21: Diseases of the Uvea and Vitreous

Signs of Acute Anterior Uveitis

• Non-pigmented KP’s• AC cells & flare• Ciliary injection• Fibrin• Hypopyon• Hypotony

Page 22: Diseases of the Uvea and Vitreous

HLA-B27 Assoc’d Uveitides

• HLA-B27 –genotype in short arm Chrom6• 50-60% in acute iritis px• Seronegative spondyloarhtropathies

– Ankylosing Spondylitis– Reiter Syndrome– IBD– Psoriatic Arthritis– Post-infectious or Reactive Arthritis

Page 23: Diseases of the Uvea and Vitreous

Ankylosing Spondylitis

• 88% HLA-B27 positive

• Chronic backache & stiffness during 2nd-3rd decades

• Sacroiliitis, sclerosis, narrowing of joint space

Page 24: Diseases of the Uvea and Vitreous

Reiter’s Syndrome• Non-specific

urethritis, polyarthritis, conjunctivitis/iritis

• 85-95% HLA-B27 positive

• Keratoderma blennorhagicum. Circinate balanitis

Page 25: Diseases of the Uvea and Vitreous

Signs of Chronic Anterior Uveitis

• Band K• Posterior synechiae• Pigmented KP’s• Cataract• Glaucoma

Page 26: Diseases of the Uvea and Vitreous

Juvenile Rheumatoid Arthritis

• Arthritis in a child < 16 y.o– Mean age : 6 y.o.

• RF (-)• Low-grade uveitis

– White eye

• Chronic, recurrent course

• Vision-threatening– Close follow-up

Page 27: Diseases of the Uvea and Vitreous

High Risk Factors

• Girls > Boys

• Pauciarticular (80-90%)

• Wrist-sparing, affects lower extremity

• ANA(+)

Page 28: Diseases of the Uvea and Vitreous

Intermediate Uveitis

• Intraocular inflammation predominantly involving the vitreous & peripheral retina

• Not part of a specific disease entity

Page 29: Diseases of the Uvea and Vitreous

Epidemiology

• 4-15 % of uveitis px

• Up to 25% of uveitis in children, mostly pars planitis

• Usually 2nd to 4th decades of life

• No sex or race predilection

• Familial intermediate uveitis

Page 30: Diseases of the Uvea and Vitreous

Pars Planitis

• Subset of intermediate uveitis

• White opacity over pars plana & ora serrata (snowbank)

• Often with worse vitritis, more severe macular edema, & worse visual prognosis

Page 31: Diseases of the Uvea and Vitreous

Signs & Symptoms

• BOV & floaters• Rarely w/ pain,

redness & photophobia

• Bilateral

• Always w/ vitritis• Snowballs • Snowbanks• Minimal AC rxn

Page 32: Diseases of the Uvea and Vitreous

Snowballs

• White & yellow • Epithelioid cells &

multinucleated giant cells which are not found in the uvea

• Inferior vitreous

Page 33: Diseases of the Uvea and Vitreous

Snowbanks• Yellowgray

exudates

• Usually in inferior ora

Page 34: Diseases of the Uvea and Vitreous

Vascular Abnormalities

• Perivasculitis

• Whitish retinal infiltrates

• Neovasc

• Cyclitic membrane

Page 35: Diseases of the Uvea and Vitreous

Complications

• CME (30%)• ODE (50%)• Vit Hem (3%)• Glaucoma (8%)• Cataract (46%)• RD (5%)• Synechiae (25%)

Page 36: Diseases of the Uvea and Vitreous

Prognosis

• More vitritis & macular edema w/ snowbanks.

• Severity of disease related to visual outcome.

• Only 5% remission.

• Burn-out eventually.

Page 37: Diseases of the Uvea and Vitreous
Page 38: Diseases of the Uvea and Vitreous

Causes of Posterior Uveitis

• Focal Retinitis– Toxoplasmosis– Onchocerciasis– Cysticercosis– Masquerade Syndrome

• Mulitfocal Retinitis– Syphilis– Herpes Simplex virus– CMV– Sarcoidosis– Masquerade– Candidiasis– Meningococcus

• Focal Choroiditis– Toxocariasis– TB– Nocardiosis– Masquerade Syndrome

• Multifocal Choroiditis– Histoplasmosis– SO– VKH– Sarcoidosis– Serpiginous Choroidopathy– Birdshot Choroidopathy– Masquerade Syndrome

(metastatic tumor)

Page 39: Diseases of the Uvea and Vitreous

Ocular Toxoplasmosis

• 30-50% of posterior uveitis

• Intracellular protozoan Toxoplasma gondii

• Def host: cat; Intermediate host: human

Page 40: Diseases of the Uvea and Vitreous

– Ingestion of encysted form (bradyzoite) w/c has predilection for cardiac, muscular, & neural tissue (e.g. retina); may lie dormant

– Rupture of cyst releases tachyzoite/ trophozoite w/ reactivation of infection

Page 41: Diseases of the Uvea and Vitreous

• Floaters,BOV

• Focal area of retinochoroiditis

• Mild to severe vitritis

• “Headlight in the fog”

– Reactivation- satellite lesion at edge of previous lesions

Page 42: Diseases of the Uvea and Vitreous

– Vasculitis and optic disc involvement

• Endpoint: scarring

Page 43: Diseases of the Uvea and Vitreous

Treatment

• Self-limited; not all needs to be treated

• Indications for treatment:– Peripapillary or posterior pole involvement– Severe vitritis w/ decreased vision

Page 44: Diseases of the Uvea and Vitreous

Treatment Regimen

• Regimen 1– Pyrimethamine

– Sulfadiazine

– Folic Acid

• Regimen 2– Clindamycin

– Sulfadiazine

• Regimen 3– Trimethoprim/

Sulfamethoxazole

• Notes– Prednisone 24 hrs.

after Ab– Never steroids alone– Duration of Tx: 2-8

weeks ( ave: 4 wks)– Endpt: scar formation

Page 45: Diseases of the Uvea and Vitreous

Prognosis

• Untreated: – retinochoroiditis resolves bet 3 wks & 6 mos

( ave: 4.2 mos)

• Treated:– Clindamycin tx results in a 2-6 wk resolution

and an 8% 3-year recurrence rate– Daraprim/sulfa results in 15% recurrence rate

Page 46: Diseases of the Uvea and Vitreous

Toxoplasmosis vs Toxocara

?+++Antiparasites

GranulomaRChoroiditisLesion

UnilateralBilateralEye Involved

NoneInt. HostHumans

DogCatDef. Host

NematodeProtozoaParasite

ToxocaraToxoplasma

Page 47: Diseases of the Uvea and Vitreous

Retinal Vasculitis

• BOV, VF loss, scotomas, floaters from secondary vitritis

• May lead to retinal ischemia, infarction, hemorrhage, neovascularization

Page 48: Diseases of the Uvea and Vitreous

Involvement of arterioles, venules, or bothPerivascular sheathing or cuffing

Page 49: Diseases of the Uvea and Vitreous

Conditions w/ Retinal Vasculitis

• Behcet’s Syndrome• Collagen-vascular dx

– WG,SLE.PAN

• Sarcoidosis• MS• IBD

• Syphilis• TB• Int. Uveitis• Toxoplasmosis• ARN• HSV/HZV/CMV• Birdshot RC• Eales’ Disease

Page 50: Diseases of the Uvea and Vitreous

Behcet’s Disease

• Systemic obliterative vasculitis

• Unknown cause• Common in Japan,

Middle East, Far East, & Mediterranean countries

Page 51: Diseases of the Uvea and Vitreous

Diagnostic Criteria

• Major Criteria– Recurrent oral ulcers

– Skin lesions

– Genital ulcers

– Ocular lesions• Recurrent hypopyon

iritis/iridocyclitis

• Chorioretinitis

• Minor Criteria– Arthritis

– GI lesions

– Epididymitis

– Vascular Lesions

– CNS Involvement• Brainstem Syndrome

• Meningoencephalomyelitic Syndrome

• Confusional Type

Page 52: Diseases of the Uvea and Vitreous

Treatment & Prognosis

• Immunosuppressives (Chlorambucil, AZT)

• Systemic corticosteroids

• 3.4 yrs to bilateral blindness +/- steroids

• 5-10% go blind in spite of all known tx

Page 53: Diseases of the Uvea and Vitreous

Vogt-Koyanagi-Harada’s Disease (VKH)

• Bilateral, diffuse granulomatous panuveitis

• Often recurrent

• Multisystemic inflammatory disease

• Involves melanocytes of uvea, retina, meninges, skin

Page 54: Diseases of the Uvea and Vitreous

Epidemiology

• More common in pigmented races

• More common in females (55-78%)

• Most in 2nd to 5th decade of life

Page 55: Diseases of the Uvea and Vitreous

Criteria for Diagnosis (AUS, 1978)

• No history of previous ocular trauma or surgery

• At least 3 of the ff:

1.Bilateral chronic iridocyclitis

2. Posterior uveitis, incl. SRD, disc hyperemia, subretinal macular edema, “sunset glow” fundus

Page 56: Diseases of the Uvea and Vitreous

3. Neurologic signs of tinnitus, neck stiffness, cranial nerve or CNS problems, CSF pleocytosis

4. Cutaneous findings such as alopecia, poliosis, or vitiligo

Page 57: Diseases of the Uvea and Vitreous

Clinical Phases

1. Prodromal Phase

2. Uveitic Phase

3. Convalescent Phase

4. Chronic Recurrent Phase

Page 58: Diseases of the Uvea and Vitreous

Traditional Treatment

• Early & aggressive use of systemic steroids, followed by slow tapering over 3 to 6 months.

• Immunosuppressive drugs used for cases refractory to steroids or when px cannot tolerate steroids.

Page 59: Diseases of the Uvea and Vitreous

White Dot Syndromes

• Several ocular disorders

• (+) Discrete light-colored lesions in fundus during at least one phase of the disease

• May be interrelated

Page 60: Diseases of the Uvea and Vitreous

White Dot Syndromes

• Multifocal Choroiditis & Panuveitis (MCP)• Multiple Evanescent White Dot Syndrome

(MEWDS)• Acute Retinal Pigment Epithelitis (ARPE)• Acute Posterior Multifocal Placoid Pigment

Epitheliopathy (APMPPE)• Birdshot Retinochoroidopathy (BRC)• Punctate Inner Choroiditis (PIC)

Page 61: Diseases of the Uvea and Vitreous

White Dot Syndromes

- BAcute18-37 FPIC

++ BGradual

40-70 FBCR

+/- BAcute15-30 M/FApmpp

- UAcute15-40 M/F ARPE

- UAcute17-38 FMewds

+ BAcute20-40 FMCP

VitritisLateralBOVAgeSex

Page 62: Diseases of the Uvea and Vitreous

Treatment

None/steroidsPIC

CSABRC

NoneAPMMPE

NoneARPE

NoneMEWDS

Steroids/immunosuppsMCP

Treatment

Page 63: Diseases of the Uvea and Vitreous

Causes of Posterior Uveitis

• Focal Retinitis– Toxoplasmosis– Onchocerciasis– Cysticercosis– Masquerade Syndrome

• Mulitfocal Retinitis– Syphilis– Herpes Simplex virus– CMV– Sarcoidosis– Masquerade– Candidiasis– Meningococcus

• Focal Choroiditis– Toxocariasis– TB– Nocardiosis– Masquerade Syndrome

• Multifocal Choroiditis– Histoplasmosis– SO– VKH– Sarcoidosis– Serpiginous Choroidopathy– Birdshot Choroidopathy– Masquerade Syndrome

(metastatic tumor)

Page 64: Diseases of the Uvea and Vitreous

Masquerade Syndrome

• Group of disorders simulating chronic uveitis

• Often mistaken for chronic idiopathic uveitis

• Many are malignant; prompt dx needed.

Page 65: Diseases of the Uvea and Vitreous

Masquerade Syndromes

• Anterior Segment– RB

– Leukemia

– IOFB

– Malignant Melanoma

– JXG

– Peripheral RD

• Posterior Segment– RP

– Reticulum Cell Sarcoma

– Lymphoma

– Malignant Melanoma

– MS

Page 66: Diseases of the Uvea and Vitreous

Tumors of the Uvea

• Iris Nevus• Choroidal Nevus• Choroidal

Hemangioma

• Iris Melanoma• Ciliary Body

Melanoma• Choroidal Melanoma

Page 67: Diseases of the Uvea and Vitreous

Iris Nevus

• Common, benign• Pigmented, flat or

slightly elevated lesion in superficial layer of iris

• Assoc’n w/ neurofibromatosis I (Lisch nodules)

Page 68: Diseases of the Uvea and Vitreous

Choroidal Melanoma

• Most common primary intraocular tumors in adults

• 6th decade of life, rarely before 30 and after 80

• Mushroom-shaped mass

• Secondary exudative RD

• Enucleation for large tumors

Page 69: Diseases of the Uvea and Vitreous

Choroidal Melanoma

Page 70: Diseases of the Uvea and Vitreous

Vitreous• 4/5 of volume of the globe

• 4.0 g, 4.0 ml

• Gel-like structure – collagen framework + hydrated hyaluronic acid

• 99% H20

• Passageway for metabolites used by lens, ciliary body, and retina

Page 71: Diseases of the Uvea and Vitreous

Functions

• Transparent medium occupying major volume of the globe

• Absorbs and redistributes forces applied to surrounding ocular tissues

Page 72: Diseases of the Uvea and Vitreous

Diseases of the Vitreous

• Vitritis

• Vitreous Hemorrhage

• Posterior Vitreous Detachment

Page 73: Diseases of the Uvea and Vitreous

Vitreous Hemorrhage

• Bleeding inside the vitreous cavity

• Sudden painless LOV or sudden appearance of black spots with flashing lights

Page 74: Diseases of the Uvea and Vitreous

Causes of Vitreous Hemorrhage

• DM Retinopathy• Retinal break• Retinal Detachment• PVD• ARMD

• Retinal Vein Occlusion

• Trauma• Tumor• Sickle-Cell Disease• Subarachnoid or

subdural hemorrhage• Others

Page 75: Diseases of the Uvea and Vitreous

Treatment

• Determine etiology• Bed rest w/ head

elevation for 2-3 days• d/c ASA, NSAIDS

unless necessary

• Surgical removal– VH +RD

– VH > 6 mos

– VH + neovasc of iris

– Hemolytic or ghost cell glaucoma

Page 76: Diseases of the Uvea and Vitreous

Posterior Vitreous Detachment (PVD)

• Posterior vitreous separates from retina and collapses toward vitreous base

Page 77: Diseases of the Uvea and Vitreous

• Floaters and flashing lights– Floaters = vitreous

opacity casting shadow on retina

– Flashing lights = physical stimulation of the retina due to vitreoretinal traction

Page 78: Diseases of the Uvea and Vitreous

Prevalence and Incidence

• 27% bet 60-69 y.o., 63% > 70 y.o.

• 10-15% asymptomatic PVD w/ retinal tear

• 70% PVD + VH w/ retinal tear

Page 79: Diseases of the Uvea and Vitreous

Management

• No Retinal Break– Follow-up closely

initially then every 6 months

– If (+) VH, treat as VH

• (+) Retinal Break– Laser or cryo tx to

prevent RD

Page 80: Diseases of the Uvea and Vitreous

Thank you very much!